Mengjie Yao - Biostatistics, Sanofi US Services Inc

基本信息

Career Trajectory

Bio

No content for now

Research Interests

Papers共 6 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Efficacy and Safety Results with Rilzabrutinib, an Oral Bruton Tyrosine Kinase Inhibitor, in Patients with Immune Thrombocytopenia: Phase 2 Part B Study

Nichola Cooper,A. J. Gerard Jansen,Robert Bird,Jiri Mayer,Michelle Sholzberg,Michael D. Tarantino,Mamta Garg,Paula F. Ypma,Vickie Mcdonald,Charles Percy,Milan Kostal,Isaac Goncalves, Lachezar H. Bogdanov,Terry B. Gernsheimer, Remco Diab,Mengjie Yao,Ahmed Daak,David J. Kuter

AMERICAN JOURNAL OF HEMATOLOGYno. 3 (2025): 439-449

Cited0Views0WOSBibtex

Efficacy and Safety of Oral Bruton Tyrosine Kinase Inhibitor (btki) Rilzabrutinib in Adults with Previously Treated Immune Thrombocytopenia (ITP): A Phase 3, Placebo-Controlled, Parallel-Group, Multicenter Study (LUNA 3)

David J Kuter,Waleed Ghanima,Nichola Cooper,Howard A. Liebman,Lei Zhang, Yu Hu,Yoshitaka Miyakawa, Luisa Elena Morales Galindo, Ana Lisa Basquiera,Chuen Wen Tan, Güray Saydam, Marie Luise Hütter-Krönke, Chatree Chai-Adisaksopha, David Gomez-Almaguer, Huy Tran, Ho-Jin Shin,Maria Cristina Pascual Izquierdo, Ilya Kirgner,Elisa Lucchini, Ganna Kuzmina, Sylvain Audia, Matias Cordoba, Remco Diab,Mengjie Yao, Michelle J. Lee,Ahmed Daak

Bloodno. Supplement 1 (2024): 5-5

Cited0Views0Bibtex

Improved Health-Related Quality of Life (hrqol) with Oral Bruton Tyrosine Kinase Inhibitor (btki) Rilzabrutinib Vs Placebo in Adults with Previously Treated Immune Thrombocytopenia (ITP): Phase 3 Luna 3 Multicenter Study

Waleed Ghanima,Howard A. Liebman, Yu Hu,Yoshitaka Miyakawa,Nichola Cooper, Güray Saydam, Marie Luise Hütter-Krönke, Sylvain Audia,Mengjie Yao,Ahmed Daak,Imene Gouia, Matias Cordoba,David J Kuter

Bloodno. Supplement 1 (2024): 2552-2552

Cited0Views0Bibtex

The Effects of Rilzabrutinib, an Oral Bruton Tyrosine Kinase Inhibitor, on Bleeding Symptoms and Health-Related Quality of Life in Patients with Immune Thrombocytopenia

Michael D. Tarantino,A. J. Gerard Jansen,Nichola Cooper,Imene Gouia,Mengjie Yao,Ahmed Daak,David J. Kuter

BLOOD (2023)

Cited0Views0Bibtex

LUNA3 Phase III Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial of the Oral BTK Inhibitor Rilzabrutinib in Adults and Adolescents with Persistent or Chronic Immune Thrombocytopenia

David J. Kuter,James B. Bussel,Nichola Cooper,Terry Gernsheimer,Michele P. Lambert,Howard Liebman,Michael D. Tarantino,Olga Bandman,Puneet Arora,Ann Neale,Regan Burns,Mengjie Yao,Waleed Ghanima

Blood（2021）

Cited8Views0Bibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn